CIK 0001781174
- Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 825125532
- Phone
- +1 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 19,904 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 184 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Development Officer gave up 403 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 60,257 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 736,767 shares at an average $1.38 ($1,017,919)
- 4 Open-market sale 10% owner sold 1,519,952 shares at an average $1.81 ($2,744,946)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Legal Officer gave up 558 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 11 · 206 filings